Glucose Biosensor Market is expected to reach $30.5 billion by 2022 - PowerPoint PPT Presentation

About This Presentation
Title:

Glucose Biosensor Market is expected to reach $30.5 billion by 2022

Description:

According to Stratistics MRC, the Global Glucose Biosensor Market is accounted for $15.3 billion in 2015 and is expected to reach $30.5 billion by 2022 growing at a CAGR of 10.29% from 2015 to 2022. – PowerPoint PPT presentation

Number of Views:72

less

Transcript and Presenter's Notes

Title: Glucose Biosensor Market is expected to reach $30.5 billion by 2022


1
Glucose Biosensor - Global Market Outlook
(2015-2022)
2
Report Description
Glucose Biosensor - Global Market Outlook
(2015-2022) Order This Report by calling
BigMarketResearch.com at 1-971-202-1575.   Accord
ing to Stratistics MRC, the Global Glucose
Biosensor Market is accounted for 15.3 billion
in 2015 and is expected to reach 30.5 billion by
2022 growing at a CAGR of 10.29 from 2015 to
2022. Growing demand for expansion of
technologically advanced products and
non-invasive products are some of the primary
factors favouring the market growth. Furthermore,
increasing frequency of diabetes across the
globe, need for early diabetes detection and
patient awareness levels are some of the drivers
fuelling the market growth. However, high cost,
reluctance towards the adoption of the new
treatment practices and slow rate of
commercialization are the restraints limiting the
market growth. The recent trends in Glucose
Biosensors market are increasing adoption of the
POC diagnostic kits and wearable healthcare
devices.   Get sample copy of report _at_
https//goo.gl/la6Ufk
3
Report Description
Fluorescence segment is expected to capture the
largest market share over the forecast period.
North America is expected to witness highest
growth rate in terms of value and share. High
disease burden and the subsequent need to curb
associated healthcare expenditure in the U.S. is
attributing to the favorable North American
market.   Some of the key players in the market
include Roche Diagnostics, LifeScan Inc., Abbott
Laboratories, Bayer, Medtronic Inc., Pinnacle
Medical Solutions Inc., AgaMatrix Inc., Sanofi
S.A., BioSense Medical Devices, LLC, Nova
Biomedical, Lifesensors, Inc., Animas
Corporation, Siemens Healthcare Diagnostics,
Inc., F. Hoffman-La Roche and M-Biotech Limited.
  End User Covered Hospitals Homecare
Diagnostics Other end users   Purchase of this
Glucose Biosensor - Global Market Outlook
(2015-2022) at USD 4150 (Single User License)
https//goo.gl/ynogqj
4
Table of Contents
Type Covered Amprometric Glucose Biosensors
Fluorescence Glucose Biosensors Other
types   Regions Covered North America o US o
Canada o Mexico Europe o Germany o France o
Italy o UK o Spain o Rest of Europe Asia
Pacific o Japan o China o India
5
Table of Contents
1 Executive Summary 2 Preface 2.1
Abstract 2.2 Stake Holders 2.3 Research
Scope 2.4 Research Methodology 2.4.1 Data
Mining 2.4.2 Data Analysis 2.4.3 Data
Validation 3 Market Trend Analysis 3.1
Introduction 3.2 Drivers 3.3 Restraints 3.4
Opportunities 3.5 Threats 3.7 End user
Analysis 3.6 Emerging Markets 
6
Table of Contents
4 Porters Five Force Analysis 4.1 Bargaining
power of suppliers 4.2 Bargaining power of
buyers 4.3 Threat of substitutes 4.4 Threat of
new entrants 4.5 Competitive rivalry 5 Global
Glucose Biosensor Market, By End User 5.1
Introduction 5.2 Hospitals 5.3 Homecare
Diagnostics 5.4 Other end users 6 Global
Glucose Biosensor Market, By Type 6.1
Introduction 6.2 Amprometric Glucose
Biosensors 6.3 Fluorescence Glucose
Biosensors 6.4 Other types 
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/glucose-biosensor
-global-outlook-2015-2022-market
Stay With Us
TELEPHONE 1-800-910-6452 EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
Write a Comment
User Comments (0)
About PowerShow.com